RobertLBettikerMD

HIV/AIDS Medicine

Associate Professor, Internal Medicine, Temple University School of Medicine

Dr. Bettiker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3401 N Broad St
Philadelphia, PA 19140
Phone+1 215-707-3807

Fax+1 215-707-4414

PubMed

3 citations
More than just oral PrEP: exploring interest in rectal douche, dissolvable implant, removable implant and injection HIV prevention approaches among racially diverse me...
Omar Martinez, Ethan Levine, Miguel Munoz-Laboy, Alex Carballo-Diéguez, José Arturo Bauermeister
BMJ Open. 2022-08-18
11 citations
Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center.
David E Koren, Volodymyra Fedkiv, Huaqing Zhao, Geena Kludjian, Robert L. Bettiker
Journal of the International Association of Providers of AIDS Care. 2020-01-01
3 citations
Ibalizumab.
Robert L Bettiker, David E Koren, Jeffrey M Jacobson
Current Opinion in HIV and AIDS. 2018-07-01

Temple University’s Plan for Mitigating COVID-19, ExplainedJuly 9th, 2020
Are Face Shields Better Than Masks for Preventing COVID-19? Doctors DebateJune 25th, 2020